Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Parkinsonism after chronic occupational exposure to glyphosate

Wang G, Fan XN, Tan YY, Cheng Q, Chen SD.

Parkinsonism Relat Disord. 2011 Jul;17(6):486-7. doi: 10.1016/j.parkreldis.2011.02.003. Epub 2011 Mar 2.

Is the answer for Parkinson disease already in the medicine cabinet?: Unfortunately not

Bower JH, Ritz B.

Neurology. 2011 Mar 8;76(10):854-5. doi: 10.1212/WNL.0b013e31820f2e7a. Epub 2011 Mar 2.

Use of ibuprofen and risk of Parkinson disease

Gao X, Chen H, Schwarzschild MA, Ascherio A.

Neurology. 2011 Mar 8;76(10):863-9. doi: 10.1212/WNL.0b013e31820f2d79. Epub 2011 Mar 2.

Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases

Mandel SA, Amit T, Weinreb O, Youdim MB.

J Alzheimers Dis. 2011;25(2):187-208. doi: 10.3233/JAD-2011-101803.

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

Stowe R, Ives N, Clarke CE, Handley K, Furmston A, Deane K, van Hilten JJ, Wheatley K, Gray R.

Mov Disord. 2011 Mar;26(4):587-98. doi: 10.1002/mds.23517. Epub 2011 Mar 2.

Interpreting the results of Parkinson's disease clinical trials: time for a change

Holford NH, Nutt JG.

Mov Disord. 2011 Mar;26(4):569-77. doi: 10.1002/mds.23555. Epub 2011 Mar 2.

Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease

Vitale C, Santangelo G, Trojano L, Verde F, Rocco M, Grossi D, Barone P.

Mov Disord. 2011 Apr;26(5):830-6. doi: 10.1002/mds.23567. Epub 2011 Mar 2.

Modulation of gait coordination by subthalamic stimulation improves freezing of gait

Fasano A, Herzog J, Seifert E, Stolze H, Falk D, Reese R, Volkmann J, Deuschl G.

Mov Disord. 2011 Apr;26(5):844-51. doi: 10.1002/mds.23583. Epub 2011 Mar 2.

ECG delta waves in patients with palpitation

Soo WM, Chong E, Teo SG, Poh KK.

Singapore Med J. 2011 Feb;52(2):68-71; quiz 72.

The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease

Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R.

Curr Pharm Des. 2011;17(5):489-507. doi: 10.2174/138161211795164095.

Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatment

Del-Bel E, Padovan-Neto FE, Raisman-Vozari R, Lazzarini M.

Curr Pharm Des. 2011;17(5):471-88. doi: 10.2174/138161211795164176.

Connecting Parkinson's disease and drug addiction: common players reveal unexpected disease connections and novel therapeutic approaches

Gramage E, Herradón G.

Curr Pharm Des. 2011;17(5):449-61. doi: 10.2174/138161211795164103.

Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease

Sun YM, Hoang T, Neubauer JA, Walters AS.

J Neurol Sci. 2011 May 15;304(1-2):93-101. doi: 10.1016/j.jns.2011.02.003. Epub 2011 Mar 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias